Ask a Gynaecologist: Four common patient questions

Ask a Gynaecologist: Four common patient questions

Harley Street Gynaecologist Mr Jeffrey Braithwaite is one of the top gynaecologists in London. He has amassed a wealth of professional knowledge and experience. Mr Braithwaite has been in private practice since 2000 and working as a gynaecologist for over 25 years. He sees patients from his clinic at 25 Harley Street and performs surgery at The Portland Hospital as well as the Weymouth Street Hospital. Mr Braithwaite has generously offered his expertise to answer common patient questions about gynaecology and obstetrics.

What is gynaecology? And what’s the difference between a gynaecologist and an obstetrician?

Gynaecology is the care of everything to do with the female reproductive system, including fertility, female cancers and the menopause. Obstetrics deals with pregnancy, childbirth and postpartum care. Many gynaecologists are obstetricians as well, as I am, and so can provide care from pre-conception to after the birth. In the US this is so prevalent, doctors in my field are called OB/GYNs. For example, I can advise on fertility issues and carry out prenatal testing and ultrasound scans.

What problems do women usually see a gynaecologist about?

Women can encounter gynaecological problems from adolescence right through to their 50s or 60s. Gynaecologists can investigate and treat issues such as pelvic pain, ovarian cancer, pelvic inflammatory disease, period problems, cervical cancer and fertility concerns. Whilst I can do fertility investigations and carry out procedures such as follicle tracking and hormone tests, I will refer patients if they need to pursue IVF.

What can a consultant gynaecologist do that a GP can’t?

General Practitioners do not have the specialist training that gynaecologists do. Some GPs have passed the Royal College of Obstetricians and Gynaecologists exam and will have the letters DRCOG after their name. This means they have an interest in the area, but will not have studied it in the depth that a consultant has. Consultants focus entirely on gynaecological issues and often have access to specialist scanning equipment and tests that GPs don’t have.

To book an appointment with Consultant Gynaecologist Mr Jeffrey Braithwaite, call 020 7224 5292.  You can also request an appointment with Mr Braithwaite via Doctify.

Icons made by Roundicons from is licensed by CC 3.0 BY
New treatments in Rheumatology

New treatments in Rheumatology

Dr Elisa Astorri, Founder of Rheumatology Harley Street, leads the way in the care and treatment of inflammatory joint disorders and autoimmune rheumatic conditions. She combines clinical expertise and the latest research with an incredibly caring and supportive manner to improve patient health.

Whilst it hasn’t been headline news, Rheumatology has changed significantly since the turn of the century – that is, the 21st century. Rheumatology is the study, care and management of musculoskeletal disorders, including rheumatoid arthritis, autoimmune disease and osteoarthritis. The focus for the treatment of patients has shifted significantly, from surgical intervention to medical, with the introduction of drugs called ‘biologics’. This has meant a huge improvement for those suffering from conditions such as arthritis, Lupus or Ankylosing spondylitis. Furthermore, GPs and patients have been looking for symptoms much earlier to guarantee an early approach to treatment – what specialists call “the window of opportunity”.

Dr Elisa Astorri

Dr Elisa Astorri

Elisa Astorri is a leading Rheumatologist who uses her research knowledge to inform patient treatment – the best of all worlds. She established Rheumatology Harley Street in 2017, and offers treatment for the full range of rheumatology conditions. Dr Astorri combines her work in the Harley Street clinic with clinical research at Queen Mary University. She completed her PhD on Sjögren’s Syndrome and has since acted as Senior Investigator on several clinical trials.

The clinical trials explore biologic drugs for autoimmune conditions, to improve the range and effectiveness of treatment. In her Rheumatology breakfast tutorial for the Independent Doctors Federation, Dr Astorri said this about biologic treatments

“We used to treat patients with generic immunosuppressants, whereas now we’re able to target specific pathways of the disease”.

Patients are in good hands with Dr Astorri, who speaks French, Italian and Spanish fluently. Over 30 five-star reviews on Doctify are a testament to her quality of care and attention to detail.

Engage. Share. Connect. The Elixir June 2017

Engage. Share. Connect. The Elixir June 2017

The Elixir June 2017 is out NOW!  … read our latest interview with Andrew Vallance-Owen, Chairman of PHIN, check out our new online health checks and social media services, not forgetting all the latest events to add to your diary and news from the DMed Blog.

[plsc_button url=”″ target=”_self” color=”black” style=”flat” radius=”square” size=”st”]Download[/plsc_button]

Don’t forget to sign up to receive your very own copy direct to your inbox.



You spent many years as the Group Medical Director at BUPA before joining PHIN, what attracted you to your current role as Chairman at PHIN?

I retired about 5 years ago from BUPA and then moved on to do non-executive work. One of the areas I was involved in when I was with BUPA was the question of clinical governance, data collection and outcome measurements and for many years I have been talking within the private sector about the need for transparency and for more information to be made available to consumers.

In particular, I was very involved with the whole question of encouraging outcome measurements involving patients directly. I chaired the Department of Health patient reported outcomes group which supported the development of that programme.

Knowing the work I was doing, Matt James, our Chief Executive asked very early on if I could now take on the Chairmanship of PHIN, and I was delighted to do so. This was a continuation of the work that I had been doing for all those years. I was very keen to bring my knowledge and experience particularly around the use of patient reported outcome measurements, and I was delighted to be part of the organisation bringing this important work to life.

The private healthcare sector is well established in the UK but in 2014 the CMA found that the information available to patients considering this option was inadequate, how will PHIN help patients make better informed choices?

In 2014 the CMA started their investigations into the private healthcare sector. They were saying what many of us have been saying for a long time, that patients in the private sector just did not have enough information to make informed decisions about where they could go and who they could see. There is a wealth of this sort of information available in the NHS but the CMA found that similar information was not available in the independent sector. It was absolutely right, and we very much supported what the CMA were saying, it is crucial to have this information. Today patients are much more discerning and demanding and they want to have information before they make their decision, this is often in consultation with their GP and so PHIN absolutely agreed with what the CMA was trying to do.


Now we have a situation where the private sector will submit data to one information body PHIN, and we will work with the private hospitals and NHS PPUs to produce consistently high quality information for patients – the consumers, on the PHIN website. In the past patient experience information was to be found on many, many websites but not in a consistent way, now PHIN is able to publish accurate, robust, and standardised information in a sensitive way that is helpful for patients.

The CMA requires that all hospitals providing privately funded healthcare including NHS hospitals are members of PHIN and that they submit patient episode data, what will you do with this data?

The data submitted to PHIN will be used to produce 11 performance measures (as specified by the CMA), which will be published on the PHIN website – supporting patients with greater information about the range, quality, and safety of care services available to them. Currently there are three performance measures published at hospital site level only – patient numbers, average length of stay, and patient satisfaction, based on the NHS Friends and Family Test (FFT). Next year this will be expanded to include additional measures – such as adverse events and patient reported outcomes (PROMs), and published for both hospitals and individual consultants.

But before publication we give every opportunity to ensure the quality and accuracy of the data. After collecting the data hospitals have the opportunity to check that the data is accurate – it is important that they trust us to get it right.

PHIN will publish consultant performance measures from next April. Consultants will want is to ensure that their data is right and we will be encouraging them to start to engage with the portal and check their data to ensure that their practice is fairly represented. We want to be as fair as we possibly can to everybody and we are doing a lot of work on engaging with the consultants to tell them that this is coming. We are not going to make judgements we are simply the facilitator to enable them to get accurate high quality data onto the PHIN website. We want to help provide clarity around healthcare data and healthcare information specifically around the 11 performance measures outlined by the CMA. The data is aggregated performance measures which provide really helpful information, context and benchmarks from which patients can arm themselves for conversations with their GP’s or referring clinicians.

Our readers will be particularly interested in the data that will be published at consultant level. Can you outline the deadlines?

At the end of April 2018 we will publish performance measures for consultants. Before that we are engaging in a process of communicating much more clearly and openly with consultants, encouraging them to come onboard with our online portal from this summer.

The consultant portal will launch this summer, it is available for hospitals now and they are already using it and we are seeing a lot of benefit for them in terms of checking and improving the accuracy of the data. The consultant portal has been piloted and the feedback from that was positive, the idea is to give the consultants six months to enable them to do their checks before publication.

Traditionally there has been little transparency in the publication of consultant fees. How are you working with doctors to ensure that what is published is valuable to patients and fair to consultants?

Absolutely – transparency in terms of fees (Article 22) is needed, and this is one of the areas the CMA identified in their report. It is a complicated area, one thing we are very sure about is that we are going to be working closely with the medical profession to come up with the best way of doing this. But the important thing is, with the publication of consultant fees now delayed till April 2019, we have been given the time to do this properly.

We have already gone out and piloted the portal once and we have used that feedback to make sure it is user friendly and to tidy it up as much as possible. When it is rolled out to consultants of course it will no longer be in pilot phase, but we are always open to improvements and want to work proactively and productively with consultants. Working with them over the next year we will be introducing them to their data and making sure that that portal is as robust and user friendly and helpful to them as possible. As we progress both for hospitals and consultants, it is very much making sure that they can check their data for accuracy and they can see what the performance measures (Article 21) are going to look like and how that has come to be.

As we move forward there is a real question in there about what other value consultants can get from this data. Consultants are generally very proud of their practice in the private sector and being able to see and publish their data is an important step forward. All doctors now have revalidation and this will be a chance for them to present a complete set of their data to appraisers, that is going to be very helpful.

– Andrew Vallance-Owen

Designated Medical would like to thank Andrew for taking the time to answer our questions.

For more information visit

Private Healthcare Information Network

January Stay Connected

Subscribe To "Stay Connected" our Monthly Medical Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!